Endoscopic screening for varices in cirrhosis: Findings, implications, and outcomes

Gastroenterology

Volumn 122, Issue 6, 2002, Pages 1620-1630

  Jensen, Dennis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE COURSE; ENDOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LIVER CIRRHOSIS; MORTALITY; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; STOMACH VARICES;

EID: 0036090959     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.33419     Document Type: Article

References (55)

1. The natural history of Laennec's cirrhosis of the liver: Analysis of 386 cases
2. Boston Interhospital Liver Group: Natural history of cirrhosis. I. Survival with esophageal varices
3. Endoscopic variceal prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices
4. Pharmacological treatment of portal hypertension: An evidence-based approach
5. Prophylactic portacaval anastomosis. A tale of two studies
6. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized clinical trials of nonsurgical treatment
7. Initial management of UGI hemorrhage in patients with portal hypertension
8. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding
9. The treatment of portal hypertension: A meta-analytic review
10. Prediction of variceal hemorrhage in cirrhosis: A prospective follow-up study
11. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy, and placebo
12. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices
13. Natural history and prognosis of variceal bleeding
14. Why do varices bleed?
15. Gastroesophageal variceal hemorrhage
16. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease
17. Career development in endoscopic research: Current status and recommendations
18. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding
19. Prediction of variceal hemorrhage by esophageal endoscopy
20. The natural history of esophageal varices in patients with alcoholic liver cirrhosis. An endoscopic and clinical study
21. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices - A prospective controlled randomized trial
22. Prediction of variceal hemorrhage: A prospective study
23. Prophylactic sclerotherapy in high risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial
24. Reliability of endoscopy in the assessment of variceal features: The Italian Liver Cirrhosis Project
25. A randomized prospective study of prophylactic rubber band ligation compared to propranolol for prevention of first variceal hemorrhage in cirrhotics with esophageal varices
26. Prophylactic sclerotherapy for esophageal varices in high risk cirrhotic patients selected by endoscopic and hemodynamic criteria: A randomized single-center controlled trial
27. The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study
28. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
29. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment
30. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective, randomized study
31. Preventative therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo
32. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial
33. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial
34. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial
35. Efficacy of prophylactic sclerotherapy for prevention of a first variceal hemorrhage
36. Prophylactic sclerotherapy of large esophageal varices
37. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients With cirrhosis
38. Prophylactic endoscopic sclerotherapy of esophageal varices in liver cirrhosis. A multicentre prospective controlled randomized trial in Vienna
39. Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: Preliminary results of a prospective controlled randomized trial
40. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial
41. Primary prevention of bleeding from esophageal varices
42. Prophylactic sclerotherapy of high-risk esophageal varices: Results of a multicenter prospective controlled trial
43. Prophylactic endoscopic sclerotherapy of esophageal varices: A prospective controlled trial
44. The natural history of esophageal varices. A retrospective study of 224 cases with liver cirrhosis
45. Prognostic indicators of risk for first variceal bleeding in cirrhosis: A multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index
46. Prospective evaluation of esophageal varices in primary biliary cirrhosis: Development, natural history and influence on survival
47. Incidence of large esophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding
48. The incidence of esophageal varices in cirrhosis
49. Prevalence, classification and natural history of gastric varices: A long-term follow-up study in 568 portal hypertension patients
50. Risk factors for hemorrhage from gastric fundal varices
51. Natural history of portal hypertension
52. Primary prophylaxis of variceal bleeding in cirrhotics: A cost effectiveness analysis
53. The economic impact of variceal hemorrhage. Cost-effectiveness implications of endoscopic therapy
54. Current management of complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis
55. Development and evaluation of the liver disease quality of life instrument in persons with advanced chronic liver disease - The LDQOL1.0